Skip to main content

Legal & General Group Plc

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 764068 London, X0

Position in REGN

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$565,614,201
-$7,906,048 QoQ
Shares Held
732,054
-1.5% QoQ
Ownership
0.698%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 90.25959833564191.ToString("F0")% Shared 0.ToString("F0")% None 9.740401664358094.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Legal & General Group Plc holds $3,030,824,133 across 242 Biotechnology names. REGN ranks #2 (18.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
732,054 $565,614,201

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $565,614,201 732,054
2025-12-31 $573,520,249 743,027
2025-09-30 $433,149,753 770,359
2025-06-30 $388,280,025 739,581
2025-03-31 $473,790,738 747,033
2024-12-31 $553,820,190 777,477
2024-09-30 $825,322,214 785,094
2024-06-30 $823,789,955 783,793
2024-03-31 $788,550,730 819,282
2023-12-31 $726,071,802 826,688
2023-09-30 $674,998,375 820,208
2023-06-30 $608,696,071 847,129
2023-03-31 $697,702,181 849,127
2022-12-31 $599,824,419 831,369
2022-09-30 $601,373,176 872,985
2022-06-30 $522,137,443 883,287
2022-03-31 $564,250,723 807,896
2021-12-31 $473,961,443 750,509
2021-09-30 $463,639,290 766,118
2021-06-30 $416,141,343 745,052
2021-03-31 $335,287,821 708,644
2020-12-31 $349,397,711 723,226
2020-09-30 $382,468,004 683,247
2020-06-30 $431,832,721 692,428
2020-03-31 $260,990,515 534,499